DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY
Clinical trials for DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY trials appear
Sign up with your email to follow new studies for DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to boost powerful cancer treatment
Disease control Not yet recruitingThis early-stage study is testing if a combination of targeted radiation and an oral antibiotic is safe and feasible to give before a patient's own immune cells are engineered to fight their cancer (CAR-T therapy). It is for adults with aggressive B-cell lymphomas that have come …
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY
Phase: PHASE1 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New immune therapy tested to boost stem cell transplant success for tough lymphomas
Disease control Not yet recruitingThis study is testing a new immune-based drug called glofitamab for adults with an aggressive type of lymphoma (DLBCL) that has returned or not responded to initial chemotherapy. The goal is to see if using glofitamab before and/or after a stem cell transplant can help control th…
Matched conditions: DIFFUSE LARGE B CELL LYMPHOMA REFRACTORY
Phase: PHASE2 • Sponsor: American University of Beirut Medical Center • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC